Atıf Formatları
Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Pamukcu Et Al. , "Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.," Current pharmaceutical design , vol.18, pp.850-60, 2012

Pamukcu, B. Et Al. 2012. Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.. Current pharmaceutical design , vol.18 , 850-60.

Pamukcu, B., Huber, K., & Lip, G., (2012). Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.. Current pharmaceutical design , vol.18, 850-60.

Pamukcu, BURAK, K Huber, And GY Lip. "Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.," Current pharmaceutical design , vol.18, 850-60, 2012

Pamukcu, BURAK Et Al. "Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.." Current pharmaceutical design , vol.18, pp.850-60, 2012

Pamukcu, B. Huber, K. And Lip, G. (2012) . "Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.." Current pharmaceutical design , vol.18, pp.850-60.

@article{article, author={BURAK PAMUKÇU Et Al. }, title={Antiplatelet therapy in atherothrombotic cardiovascular diseases for primary and secondary prevention: a focus on old and new antiplatelet agents.}, journal={Current pharmaceutical design}, year=2012, pages={850-60} }